Thus, when 4-carbomethoxyl-10-epigyrosanoldie E inhibits RhoA expression, this leads to a decrease in MMP-2 and MMP-9 levels, impacting the migration and invasion of Cal-27 and Ca9-22 oral cancer cells. Here, MMP2 is linked to lip and oral cavity carcinoma.